![Jason Campagna](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Campagna
Technik-/Wissenschafts-/F&E-Leiter bei
INVENTIVA
Profil
Jason A. Campagna currently works at Inventiva SA, as Chief Medical Officer & President-Research from 2025.
Dr. Campagna also formerly worked at Annovation BioPharma, Inc., as Director, Profibrix BV, as Managing Director, Altus Copper Corp., as Independent Director from 2021 to 2023, The Medicines Co., as Senior VP-Surgery & Perioperative Care, Intercept Pharmaceuticals, Inc., as Chief Medical Officer & Senior Vice President from 2019 to 2021, Q32 Bio, Inc., as Chief Medical Officer from 2021 to 2025, and Q32 Bio Operations, Inc., as Chief Medical Officer.
Dr. Campagna received his undergraduate degree, graduate degree, and doctorate degree from the University of Miami.
Aktive Positionen von Jason Campagna
| Unternehmen | Position | Beginn |
|---|---|---|
| INVENTIVA | Technik-/Wissenschafts-/F&E-Leiter | 30.07.2025 |
Ehemalige bekannte Positionen von Jason Campagna
| Unternehmen | Position | Ende |
|---|---|---|
| ALTUS COPPER CORP. | Direktor/Vorstandsmitglied | 31.03.2023 |
| INTERCEPT PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 05.03.2021 |
| THE MEDICINES COMPANY | Corporate Officer/Principal | 01.08.2016 |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Jason Campagna
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
7
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Annovation BioPharma, Inc.
 Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products in the field of anesthesia, sedation and sleep | Health Technology |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology Develops and markets products for the hemostasis and regenerative medicine markets | Health Technology |
Inventiva SA
 Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
Plantable Health, Inc.
 Plantable Health, Inc. Pharmaceuticals: OtherHealth Technology Produces and sells plant-based meal products | Health Technology |
